Answer given by Mr Barrot on behalf of the Commission (2 December 2009) On 3 March 2008 the Council adopted Council Decision 2008/206/JHA OJ L 63, 7.3.2008. , defining 1-benzylpiperazine (BZP) as new psychoactive substance which is to be made subject to control measures and criminal proceedings, such in accordance with Article 8 (3) of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances. Article 9 (1) of Council Decision 2005/387/JHA asks Member States to ‘endeavour to take, as soon as possible, but no later than one year from the date of that decisions, the necessary measures in accordance with their national law to submit: (a) the new psychotropic drug to control measures and criminal penalties as provided under their legislation by virtue of their obligations under the 1971 United Nations Convention on Psychotropic Substances As BZP is a synthetic, psychotropic substance, the 1971 UN Convention on psychotropic substances applies. ’. Article 9 (2) of Council Decision 2005/387/JHA indicates that ‘Member States shall report the measures taken to both the Council and the Commission as soon as possible after the relevant decision has been taken. Thereafter this information shall be communicated to the European Monitoring Centre for Drugs and Drug Addiction (MMCDDA), the European Police Office (Europol), the European Medicines Agency (EMEA), and the European Parliament’. On the 8th of May 2009, the Council Secretariat sent out a reminder to all Member States, asking for information on the follow up of Council Decision on BZP. By July 2009, 19 Member States had reported to the Council and/or the Commission that BZP has been made subject to control measures and criminal proceedings or that draft legislation was underway. In preparation of this answer, the Commission has also made use of the information available in the EMCDDA's legal database on drugs. When combined, the following overview can be provided. Countries that made BZP subject to control measures and criminal sanctions prior to Council Decision 2008/206/JHA: — Belgium (2004), Denmark (2005), Estionia (2007), Greece (2003), Italy (2007), Lithuania (2007), Malta (2006) and Sweden (2003). Countries that made BZP subject to control measures and criminal sanctions after the adoption of Council Decision 2008/206/JHA: — Bulgaria (2009), Czech Republic (2009), Germany (2008), Ireland (2009), Spain (2009), France (2009), Cyprus (2009), Latvia (2009), Luxembourg (2009), Hungary (2009), Netherlands (2009), Austria (2009), Poland (2009), Portugal (2009), Slovakia (2009), Finland (2008). Countries for which a decision on making BZP subject to control measures and criminal sanctions is still pending: — Romania: in May 2009, legislation was under preparation. No information has been received about further developments. — Slovenia: the procedure for including BZP in the list of controlled substances is ongoing and will probably be finalised by the end of November 2009. — United Kingdom: an order to control BZP was laid before Parliament on 19 October 2009. BZP is made part of a proposal on a generic approach to piperazines. Subject to Parliamentary agreement, BZP will be controlled under the Misuse of Drugs Act 1971 as a Class C drug on 23 December